These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35260782)

  • 1. Targeted metabolomics analysis of serum and Mycobacterium tuberculosis antigen-stimulated blood cultures of pediatric patients with active and latent tuberculosis.
    Magdalena D; Michal S; Marta S; Magdalena KP; Anna P; Magdalena G; Rafał S
    Sci Rep; 2022 Mar; 12(1):4131. PubMed ID: 35260782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers.
    Albors-Vaquer A; Rizvi A; Matzapetakis M; Lamosa P; Coelho AV; Patel AB; Mande SC; Gaddam S; Pineda-Lucena A; Banerjee S; Puchades-Carrasco L
    Emerg Microbes Infect; 2020 Dec; 9(1):1131-1139. PubMed ID: 32486916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based identification of new serum biomarkers in patients with latent infection pulmonary tuberculosis.
    Li YX; Zheng KD; Duan Y; Liu HJ; Tang YQ; Wu J; Lin DZ; Zhang Z
    Medicine (Baltimore); 2022 Dec; 101(48):e32153. PubMed ID: 36482536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection.
    Xiao JN; Xiong Y; Chen Y; Xiao YJ; Ji P; Li Y; Wang SJ; Zhao GP; Cheng QJ; Lu SH; Wang Y
    Front Cell Infect Microbiol; 2017; 7():495. PubMed ID: 29250493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection.
    Wayengera M; Kateete DP; Asiimwe B; Joloba ML
    BMC Infect Dis; 2018 Mar; 18(1):133. PubMed ID: 29548281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
    Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary metabolomic analysis to identify potential markers for the diagnosis of tuberculosis and latent tuberculosis.
    Deng J; Liu L; Yang Q; Wei C; Zhang H; Xin H; Pan S; Liu Z; Wang D; Liu B; Gao L; Liu R; Pang Y; Chen X; Zheng J; Jin Q
    Arch Biochem Biophys; 2021 Jun; 704():108876. PubMed ID: 33864753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis.
    Lubbers R; Sutherland JS; Goletti D; de Paus RA; van Moorsel CHM; Veltkamp M; Vestjens SMT; Bos WJW; Petrone L; Del Nonno F; Bajema IM; Dijkman K; Verreck FAW; Walzl G; Gelderman KA; Groeneveld GH; Geluk A; Ottenhoff THM; Joosten SA; Trouw LA
    Front Immunol; 2018; 9():2427. PubMed ID: 30405622
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis.
    Chiappini E; Della Bella C; Bonsignori F; Sollai S; Amedei A; Galli L; Niccolai E; Del Prete G; Singh M; D'Elios MM; de Martino M
    PLoS One; 2012; 7(9):e46041. PubMed ID: 23029377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection.
    Mehaffy C; Kruh-Garcia NA; Graham B; Jarlsberg LG; Willyerd CE; Borisov A; Sterling TR; Nahid P; Dobos KM
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32245831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.
    Teklu T; Kwon K; Wondale B; HaileMariam M; Zewude A; Medhin G; Legesse M; Pieper R; Ameni G
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum proteomics analysis for differentiation among Mycobacterium tuberculosis infection categories.
    Kaewseekhao B; Sirichoat A; Roytrakul S; Yingchutrakul Y; Reechaipichitkul W; Faksri K
    Tuberculosis (Edinb); 2023 Jul; 141():102366. PubMed ID: 37379738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncloaking an ancient adversary: Can pathogen biomarker elicitors play a role in confirming extrapulmonary TB and latent TB infection?
    Porter BW; Venkatappa TK
    Tuberculosis (Edinb); 2018 Dec; 113():30-37. PubMed ID: 30514511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.
    de Araujo LS; Ribeiro-Alves M; Leal-Calvo T; Leung J; Durán V; Samir M; Talbot S; Tallam A; Mello FCQ; Geffers R; Saad MHF; Pessler F
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach.
    Cho Y; Park Y; Sim B; Kim J; Lee H; Cho SN; Kang YA; Lee SG
    Sci Rep; 2020 Mar; 10(1):3825. PubMed ID: 32123207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.